BECTON, DICKINSON AND COMPANY Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
BECTON, DICKINSON AND COMPANY (BDX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.00% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was 0.00%, a 100.00% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 2.20%.
- BECTON, DICKINSON AND COMPANY effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.00%.
- BECTON, DICKINSON AND COMPANY effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2025-09-30 | 0.00% 10-K · filed 2025-11-25 |
| 2024-09-30 | 2.20% 10-K · filed 2025-11-25 |
| 2023-09-30 | 0.00% 10-K · filed 2025-11-25 |
| 2022-09-30 | 0.00% 10-K · filed 2024-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |